Japan Vietnam Medical Instrument JSC (JVC) — Cash Flow Reinvestment Rate

Latest as of December 2022: 7.90x

Japan Vietnam Medical Instrument JSC (JVC) has a Cash Flow Reinvestment Rate of 7.90x as of December 2022, reinvesting ₫17.44 Billion (capex ₫10.94 Billion plus investments ₫-6.51 Billion) from operating cash flow of ₫2.21 Billion. Check JVC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

7.90x
(Capex + Investments) / Operating CF

Total Reinvested

₫17.44 Billion
Capex + Investments

Operating Cash Flow

₫2.21 Billion
VND

Capital Expenditures

₫10.94 Billion
VND

Japan Vietnam Medical Instrument JSC Cash Flow Reinvestment Rate (2015–2022)

Historical reinvestment intensity for Japan Vietnam Medical Instrument JSC across 5 annual periods. Explore JVC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Japan Vietnam Medical Instrument JSC (2015–2022)

Year-by-year capital reinvestment analysis for Japan Vietnam Medical Instrument JSC. For live market cap and broader valuation context, see JVC market cap overview.

Year Reinvestment Rate Total Reinvested (VND) Operating CF Capex YoY Change
2022 1.47x ₫61.96 Billion ₫42.10 Billion ₫31.38 Billion ▼ -31.4%
2021 2.15x ₫272.63 Billion ₫127.02 Billion ₫40.81 Billion ▲ +24.1%
2020 1.73x ₫53.09 Billion ₫30.71 Billion ₫22.45 Billion ▲ +203.7%
2017 0.57x ₫43.34 Billion ₫76.13 Billion ₫42.59 Billion ▼ -97.8%
2015 25.73x ₫67.16 Billion ₫2.61 Billion ₫52.56 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow